UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
This paper provides a critical review of several possible mechanisms at different levels of analysis underlying the effects and therapeutic potential of psychedelics.
Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience
In this mixed methods online suWe aimed to develop an understanding of frequently used psych
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial
At-home KAT response and remission rates indicated rapid and significant antidepressant and anxiolytic effects.
Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey
Here, we report results from an online survey conducted between August 2020 and July 2021 in a population of 250 chronic pain sufferers.
Psychedelics, mystical experience, and therapeutic efficacy: A systematic review
In this review, 12 studies of psychedelic therapy utilizing psilocybin, ayahuasca, or ketamine were analyzed for association between mystical experience and symptom reduction.
From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary development of the Relaxed Beliefs Questionnaire (REB-Q).
We report the first empirical evidence that the relaxation and revision of negative self-belief confidence mediates positive psychological outcomes.
Psychedelics in the treatment of unipolar and bipolar depression
This is a narrative review about the role of classic and two atypical psychedelics in the treatment of unipolar and bipolar depression.
Decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees
Results suggest rapid and persisting (up to 1 week) anxiolytic effects in individuals with sub-clinical anxiety symptoms
Sustained effects of single doses of classical psychedelics in humans
A unique and compelling feature of psychedelics is that intake of just a single psychedelic dose is associated with long-lasting effects.
Language models learn sentiment and substance from 11,000 psychoactive experiences
MDMA was singularly linked to mid-experience swelling of "Love", potent psychedelics like DMT, and 5-MeO-DMT were associated with "Mystical Experiences".
MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial
These findings provide preliminary support for the efficacy and safety of MDMA-AT for treating PTSD across ethnoracial groups.
Studying close entity encounters of the psychedelic kind: Insights from the cognitive evolutionary science of religion
This article focuses on lessons learned by CESR (cognitive-evolutionary science of religion) scholars that might provide inspiration for scholars in SPE (science of psychedelic experiences)
Ketamine for bipolar depression: Biochemical, psychotherapeutic, and psychedelic approaches
This article expands on the existing research by articulating three different paradigms for ketamine treatment: biochemical, psychotherapeutic, and psychedelic.
Positive psychology & psychedelics: possible synergies
MDMA-assisted approaches can turbo-charge savouring/compassion/gratitude positive affect treatments.
Braxia Scientific presents positive preliminary findings from phase II randomized, multi-dose clinical trial of psilocybin-assisted therapy for treatment resistant depression
Positive preliminary results from the first Health Canada Approved, Phase II, randomized clinical trial to evaluate psilocybin-assisted therapy for Treatment-Resistant-Depression.